234 related articles for article (PubMed ID: 37400440)
21. CLN3 regulates endosomal function by modulating Rab7A-effector interactions.
Yasa S; Modica G; Sauvageau E; Kaleem A; Hermey G; Lefrancois S
J Cell Sci; 2020 Mar; 133(6):. PubMed ID: 32034082
[TBL] [Abstract][Full Text] [Related]
22. S. pombe btn1, the orthologue of the Batten disease gene CLN3, is required for vacuole protein sorting of Cpy1p and Golgi exit of Vps10p.
Codlin S; Mole SE
J Cell Sci; 2009 Apr; 122(Pt 8):1163-73. PubMed ID: 19299465
[TBL] [Abstract][Full Text] [Related]
23. Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease.
Järvelä I; Sainio M; Rantamäki T; Olkkonen VM; Carpén O; Peltonen L; Jalanko A
Hum Mol Genet; 1998 Jan; 7(1):85-90. PubMed ID: 9384607
[TBL] [Abstract][Full Text] [Related]
24. Partial correction of the CNS lysosomal storage defect in a mouse model of juvenile neuronal ceroid lipofuscinosis by neonatal CNS administration of an adeno-associated virus serotype rh.10 vector expressing the human CLN3 gene.
Sondhi D; Scott EC; Chen A; Hackett NR; Wong AM; Kubiak A; Nelvagal HR; Pearse Y; Cotman SL; Cooper JD; Crystal RG
Hum Gene Ther; 2014 Mar; 25(3):223-39. PubMed ID: 24372003
[TBL] [Abstract][Full Text] [Related]
25. A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis.
Kitzmüller C; Haines RL; Codlin S; Cutler DF; Mole SE
Hum Mol Genet; 2008 Jan; 17(2):303-12. PubMed ID: 17947292
[TBL] [Abstract][Full Text] [Related]
26. Intracellular trafficking of CLN3, the protein underlying the childhood neurodegenerative disease, Batten disease.
Mao Q; Xia H; Davidson BL
FEBS Lett; 2003 Dec; 555(2):351-7. PubMed ID: 14644441
[TBL] [Abstract][Full Text] [Related]
27. Biochemistry of neuronal ceroid lipofuscinoses.
Junaid MA; Pullarkat RK
Adv Genet; 2001; 45():93-106. PubMed ID: 11332778
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of lysosomal acid phosphatase in CLN3-defective cells and mouse brain tissue.
Pohl S; Mitchison HM; Kohlschütter A; van Diggelen O; Braulke T; Storch S
J Neurochem; 2007 Dec; 103(6):2177-88. PubMed ID: 17868323
[TBL] [Abstract][Full Text] [Related]
29. A dileucine motif and a cluster of acidic amino acids in the second cytoplasmic domain of the batten disease-related CLN3 protein are required for efficient lysosomal targeting.
Storch S; Pohl S; Braulke T
J Biol Chem; 2004 Dec; 279(51):53625-34. PubMed ID: 15469932
[TBL] [Abstract][Full Text] [Related]
30. Altered gene expression in the eye of a mouse model for batten disease.
Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
[TBL] [Abstract][Full Text] [Related]
31. Mutated genes in juvenile and variant late infantile neuronal ceroid lipofuscinoses encode lysosomal proteins.
Vesa J; Peltonen L
Curr Mol Med; 2002 Aug; 2(5):439-44. PubMed ID: 12125809
[TBL] [Abstract][Full Text] [Related]
32. CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease.
Luiro K; Kopra O; Lehtovirta M; Jalanko A
Hum Mol Genet; 2001 Sep; 10(19):2123-31. PubMed ID: 11590129
[TBL] [Abstract][Full Text] [Related]
33. Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.
Chan CH; Mitchison HM; Pearce DA
Hum Mol Genet; 2008 Nov; 17(21):3332-9. PubMed ID: 18678598
[TBL] [Abstract][Full Text] [Related]
34. Retromer has a selective function in cargo sorting via endosome transport carriers.
Cui Y; Carosi JM; Yang Z; Ariotti N; Kerr MC; Parton RG; Sargeant TJ; Teasdale RD
J Cell Biol; 2019 Feb; 218(2):615-631. PubMed ID: 30559172
[TBL] [Abstract][Full Text] [Related]
35. Two motifs target Batten disease protein CLN3 to lysosomes in transfected nonneuronal and neuronal cells.
Kyttälä A; Ihrke G; Vesa J; Schell MJ; Luzio JP
Mol Biol Cell; 2004 Mar; 15(3):1313-23. PubMed ID: 14699076
[TBL] [Abstract][Full Text] [Related]
36. Intracellular trafficking of the JNCL protein CLN3.
Haskell RE; Derksen TA; Davidson BL
Mol Genet Metab; 1999 Apr; 66(4):253-60. PubMed ID: 10191111
[TBL] [Abstract][Full Text] [Related]
37. Deletion of the Caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotype.
de Voer G; van der Bent P; Rodrigues AJ; van Ommen GJ; Peters DJ; Taschner PE
J Inherit Metab Dis; 2005; 28(6):1065-80. PubMed ID: 16435200
[TBL] [Abstract][Full Text] [Related]
38. Novel interactions of CLN3 protein link Batten disease to dysregulation of fodrin-Na+, K+ ATPase complex.
Uusi-Rauva K; Luiro K; Tanhuanpää K; Kopra O; Martín-Vasallo P; Kyttälä A; Jalanko A
Exp Cell Res; 2008 Sep; 314(15):2895-905. PubMed ID: 18621045
[TBL] [Abstract][Full Text] [Related]
39. Batten disease: evaluation of CLN3 mutations on protein localization and function.
Haskell RE; Carr CJ; Pearce DA; Bennett MJ; Davidson BL
Hum Mol Genet; 2000 Mar; 9(5):735-44. PubMed ID: 10749980
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms of the juvenile form of Batten disease: important role of MAPK signaling pathways (ERK1/ERK2, JNK and p38) in pathogenesis of the malady.
Shematorova EK; Shpakovski DG; Chernysheva AD; Shpakovski GV
Biol Direct; 2018 Sep; 13(1):19. PubMed ID: 30621751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
